Leaflet NANOHSA-ROTOP 0.5mg kit for radiopharmaceutical preparations


Indicated for: diagnostic imaging

Route of administration: injectable

Substance: Tc 99 m - human albumin (contrast agent)

ATC: V09DB01 (Various | Hepatic and reticulo endothelial system | Technetium (99mtc), particles and colloids)

Tc-99m-human albumin is a radiopharmaceutical used in medical imaging to evaluate cardiac function, blood circulation, and fluid accumulation in the body. It binds to plasma proteins, allowing visualization of blood flow and fluid distribution.

The medication is administered intravenously, and images are obtained using a gamma camera. It is important for patients to follow the doctor's instructions before and after the procedure.

Patients should be aware of potential adverse reactions, such as allergic reactions or discomfort at the injection site. It is important to inform the doctor of any unusual symptoms.

Side effects are rare but may include allergic reactions, nausea, or skin rashes. Patients should be informed of these risks before the procedure.

General data about NANOHSA-ROTOP 0.5mg

  • Substance: Tc 99 m - human albumin
  • Date of last drug list: 01-08-2024
  • Commercial code: W67761001
  • Concentration: 0.5mg
  • Pharmaceutical form: kit for radiopharmaceutical preparations
  • Quantity: 5
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: ROTOP PHARMAKA GMBH - GERMANIA
  • Holder: TORUS PHARMA COMPANY SRL - ROMANIA
  • Number: 623/2021/01
  • Shelf life: 24 months

Pharmaceutical forms available for Tc 99 m - human albumin

Concentrations available for Tc 99 m - human albumin

  • 0.5mg
  • 2.5mg